SCHEMBL11943190

SCHEMBL11943190

CS(=O)(=O)c1ccccc1S(=O)(=O)N1CCN(c2cnn(-c3ccccc3)c(=O)c2NCc2cccnc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.48
▸ DCTPP1 Q9H773 1/20 0.48
▸ MAPT P10636 5/20 0.47
▸ LMNA P02545 3/20 0.47
▸ NAMPT P43490 6/20 0.45
▸ GAA P10253 4/20 0.44
▸ PKM P14618 2/20 0.44
▸ NPBWR1 P48145 1/20 0.42
▸ MCHR1 Q99705 1/20 0.42
▸ POLB P06746 2/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11943292 0.90 MAPT (0.50) ALDH1A1DCTPP1MAPTLMNANAMPT
SCHEMBL11943309 0.85 NAMPT (0.52) ALDH1A1DCTPP1MAPTLMNANAMPT
SCHEMBL11943226 0.78 DCTPP1 (0.44) ALDH1A1DCTPP1MAPTLMNANAMPT
SCHEMBL11943311 0.77 POLB (0.47) ALDH1A1DCTPP1MAPTLMNAGAA
SCHEMBL11943222 0.76 DCTPP1 (0.51) ALDH1A1DCTPP1MAPTLMNAPKM
SCHEMBL11943132 0.76 MAPT (0.46) ALDH1A1DCTPP1MAPTLMNAGAA
SCHEMBL13329325 0.75 ALDH1A1 (0.51) ALDH1A1DCTPP1MAPTLMNAPKM
SCHEMBL11946601 0.73 ALDH1A1 (0.54) ALDH1A1DCTPP1MAPTLMNAPOLB
SCHEMBL11943162 0.73 SMN1; SMN2 (0.41) ALDH1A1DCTPP1MAPTLMNANAMPT
SCHEMBL11943257 0.72 MAPT (0.48) ALDH1A1DCTPP1MAPTLMNANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-8232274-B2 Pyridazinone derivatives useful as glucan synthase inhibitors ALBANY MOLECULAR RESEARCH, INC. (US) 2012-07-31 — — US disclosed
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS SCHERING CORPORATION (US) 2010-06-24 — — US disclosed
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS SCHERING CORPORATION (US) 2010-06-24 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors SCHERING CORPORATION AND ALBANY MOLECULAR RESEARCH, INC. 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170861-A1 Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors MAN2A1, GYS2, MANBA ALDH1A1 2437/4885DCTPP1 625/4885MAPT 2295/4885
US-20100158992-A1 PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS DPM1, GMPS, MAN2A1 ALDH1A1 2003/4885DCTPP1 209/4885MAPT 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback